ANIP R&D to Revenue
Ani Pharmaceuticals Inc · R&D to Revenue
ANIP R&D to Revenue
Latest reported5.85%period ending
ANIP FY R&D/Revenue (1137.75% → 5.85%)
Latest values, visible window
High-resolution chart · PNG
ANIP r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 5.8485% | |
| 7.2563% | |
| 7.0429% | |
| 7.0541% | |
| 5.2601% | |
| 7.6753% | |
| 9.5891% | |
| 7.6338% | |
| 5.1289% | |
| 2.2593% | |
| 3.7656% | |
| 4.7847% | |
| 5.6911% | |
| 734.0629% | |
| 10,153.1069% | |
| 1,604.7574% | |
| 1,087.4393% | |
| 417.6327% | |
| 963.6496% | |
| 26.7038% | |
| 2,480.7645% | |
| 11,763.9101% | |
| 5,636.272% | |
| 168.9157% | |
| 122.5799% | |
| 0% | |
| 0% | |
| 1,137.752% |